Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Karyopharm Therapeut (NQ: KPTI ) 0.8080 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Karyopharm Therapeut < Previous 1 2 3 4 5 6 Next > Expert Ratings for Karyopharm Therapeutics September 09, 2022 Analysts have provided the following ratings for Karyopharm Therapeutics (NASDAQ:KPTI) within the last quarter: Via Benzinga Where Karyopharm Therapeutics Stands With Analysts September 09, 2022 Karyopharm Therapeutics (NASDAQ:KPTI) has observed the following analyst ratings within the last quarter: Via Benzinga HashiCorp, Pagerduty, Lululemon And Some Other Big Stocks Moving Higher In Today's Pre-Market Session September 02, 2022 Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) surged 13.5% to $19.25 in pre-market trading. A consortium led by Hollysys Automation’s management is looking to take the US-listed company private... Via Benzinga Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket September 02, 2022 Gainers Via Benzinga Karyopharm Therapeutics Earnings Perspective: Return On Capital Employed August 18, 2022 Via Benzinga Analyst Ratings for Karyopharm Therapeutics May 05, 2022 Analysts have provided the following ratings for Karyopharm Therapeutics (NASDAQ:KPTI) within the last quarter: Via Benzinga Recap: Karyopharm Therapeutics Q1 Earnings May 05, 2022 Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Karyopharm Therapeutics: Q2 Earnings Insights August 04, 2022 Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday August 02, 2022 Tuesday's session saw 63 companies set new 52-week lows. Via Benzinga Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners July 21, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Karyopharm Shares Soar Following European Commission's Marketing Authorisation For Multiple Myeloma Candidate July 21, 2022 The European Commission (EC) has granted Marketing Authorisation for Karyopharm Therapeutics’ (NASDAQ: KPTI) lead candidate NEXPOVIO (selinexor) in combination with once-weekly bortezomib (Velcade) and... Via Benzinga Recap of Wednesday's Biotech Catalysts - End of The Day Summary July 20, 2022 Via Benzinga Karyopharm Shares Soar On FDA Fast Track Status, EU Orphan Medicinal Product Status To Preleukemia Candidate July 20, 2022 The U.S. Food and Drug Administration (FDA) has granted fast track designation to Karyopharm Therapeutics’ (NASDAQ: KPTI) lead asset Eltanexor as monotherapy for the treatment of patients with relapsed... Via Benzinga The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK June 16, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Karyopharm Therapeutics' Shares Slide After Biogen Terminates 2018 Asset Purchase Agreement June 15, 2022 Via Benzinga Looking Into Karyopharm Therapeutics's Return On Capital Employed May 27, 2022 Karyopharm Therapeutics (NASDAQ:KPTI) brought in sales totaling $47.67 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 206.92%, resulting in a loss of $41.40... Via Benzinga The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study May 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Karyopharm Therapeutics Earnings Preview May 04, 2022 Karyopharm Therapeutics (NASDAQ:KPTI) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga What 5 Analyst Ratings Have To Say About Karyopharm Therapeutics March 18, 2022 Over the past 3 months, 5 analysts have published their opinion on Karyopharm Therapeutics (NASDAQ:KPTI) stock. These analysts are typically employed by large Wall Street banks... Via Benzinga The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data March 17, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Mid-Afternoon Market Update: Dow Gains 2%; SAB Biotherapeutics Shares Slide March 02, 2022 U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 2% on Wednesday. The Dow traded up 2.07% to 33,983.50 while the NASDAQ rose 1.77% to 13,771.67. The... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session March 02, 2022 Gainers Trevi Therapeutics (NASDAQ:TRVI) shares rose 46.6% to $1.28 during Wednesday's regular session. As of 12:30 EST, Trevi Therapeutics's stock is trading at a... Via Benzinga 68 Biggest Movers From Yesterday March 03, 2022 Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to... Via Benzinga 41 Stocks Moving In Wednesday's Mid-Day Session March 02, 2022 Gainers ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday. Nordstrom, Inc. (NYSE: JWN) shares jumped 38.7% to $27.11 after the company reported... Via Benzinga Mid-Day Market Update: Nasdaq Surges 150 Points; US Crude Oil Inventories Fall By 2.6M Barrels March 02, 2022 U.S. stocks extended gains midway through trading, with the Nasdaq index jumping 150 points on Wednesday. The Dow traded up 1.71% to 33,865.43 while the NASDAQ rose 1.11% to 13,... Via Benzinga Mid-Morning Market Update: U.S. Stocks Mixed; Dollar Tree Reports Mixed Q4 Results March 02, 2022 U.S. stocks opened mixed this morning, with the Dow Jones adding more than 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.66% to 33,513.04... Via Benzinga Where Karyopharm Therapeutics Stands With Analysts March 02, 2022 Karyopharm Therapeutics (NASDAQ:KPTI) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 02, 2022 Gainers IsoPlexis (NASDAQ:ISO) shares moved upwards by 22.8% to $5.5 during Wednesday's pre-market session. The company's market cap stands at $214.2 million. The... Via Benzinga The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi March 02, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Karyopharm Says FDA Mandates Additional Study For Expanding Selinexor Label... Via Benzinga Why Are Karyopharm Shares Trading Lower Today March 02, 2022 Karyopharm Therapeutics Inc (NASDAQ: KPTI) stock plunged after an update on its supplemental New Drug Application submission based on the Phase 3 SIENDO study data... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.